Tag: Motley Fool

  • 3 top ASX 200 shares to buy in January

    A group of young ASX investors sitting around a laptop with an older lady standing behind them explaining how the ASX 200 works

    Investors that are looking for some new shares to buy in January may want to look at the ones listed below.

    These three ASX shares may be from very different areas of the market but one thing they have in common is that they have been tipped to climb higher from here. They are as follows:

    Aristocrat Leisure Limited (ASX: ALL)

    The first ASX share to look at is Aristocrat Leisure. It is one of the world’s leading gaming technology companies. Aristocrat has a portfolio of world class pokie machines and a growing digital business which has become a significant contributor to its earnings in recent years. That latter is being driven by the increasing popularity of games such as Raid. The company is also in the process of acquiring London-listed leading global online gambling software and content supplier, Playtech, for $5 billion. All in all, this has analysts tipping Aristocrat to continue its strong growth in the coming years.

    Morgans is positive on the company. It currently has an add rating and $52.00 price target on its shares.

    Goodman Group (ASX: GMG)

    Another ASX share that could be in the buy zone is Goodman. It is a global integrated commercial and industrial property company with operations throughout Australia, New Zealand, Asia, Europe, the United Kingdom, North America and Brazil. Goodman has a world class portfolio of properties which have exposure to key growth markets such as ecommerce and logistics. Thanks to strong demand for these properties, Goodman has been growing at a rapid rate over the last decade and has been tipped to continue doing so in the future.

    Citi is very positive on Goodman. Its analysts currently have a buy rating and $27.50 price target on its shares.

    Nanosonics Ltd (ASX: NAN)

    A final ASX share to look at is Nanosonics. It is one of the world’s leading infection prevention companies. At present, Nanosonics is best known for its industry-leading trophon EPR disinfection system for ultrasound probes. However, management is in the process of expanding its portfolio with several new products. One of these is the Nanosonics Coris platform. This new platform, which is expected to be launched in calendar year 2023, is for cleaning flexible endoscopes. This could be an even bigger market than ultrasound probe disinfection.

    Morgans is also bullish on Nanosonics. Its analysts have an add rating and $6.97 price target on its shares.

    The post 3 top ASX 200 shares to buy in January appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of August 16th 2021

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Nanosonics Limited. The Motley Fool Australia owns and has recommended Nanosonics Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3zvCfGw

  • These were the best-performing ASX cannabis shares in 2021

    A farmer in a field of cannabis plants.

    ASX cannabis shares were a mixed bag in 2021 with the broad sector showing weakness across the entire year. Several of the majors underperformed, while key players continued to sprout through.

    Checking the trade quotes for cannabis stocks listed on the Australian exchanges, it’s abundantly clear most names are swimming in a sea of red across all time frames.

    Yet, despite the broad-sector weakness, there were still pockets of green littered throughout the ASX cannabis space last year.

    With 2022 now well underway, let’s look back and observe some of the top-performing ASX cannabis shares in 2021.

    Cronos Australia Ltd (ASX: CAU)

    Shares in medicinal cannabinoid player Cronos continued charging higher in 2021 and bounced from a low of 10.5 cents in September to close the year at 20 cents.

    The company advised of a key update back in December that is likely to be of critical importance to operations from 2022.

    Mid-month Cronos announced it had completed its merger with CDA Health Pty Ltd. Pursuant to the merger, four directors of Cronos handed in their resignations and new directors have been appointed.

    The company paid $5 million in cash and issued a total of 403,552,399 ordinary shares to CDA shareholders and has consideration to purchase of 100% of the shares in CDA Health.

    As a result, CDA Health is now a wholly owned subsidiary of Cronos Australia. Former shareholders of CDA Health now own approximately 74% of Cronos Australia’s issued capital (on an undiluted basis).

    The new entity is forecasted to deliver proforma FY21 revenue of $23.1 million – up from $4.6 million the year prior. However, the cost of these revenues is expected to widen to over $15 million from $2.58 million in FY20.

    Cronos finished the year 54% higher after gaining support towards the the back end of the year. Its shares are now trading at 29 cents apiece.

    Incannex Healthcare Ltd (ASX: IHL)

    Shares in medicinal ASX cannabis company Incannex Healthcare recovered from downward pressure in December and finished the year well in the green.

    Investors who held Incannex for the entirety of 2021 saw their holdings increase by more than 294%, only dipping along the way alongside broad-sector weakness.

    Investors weren’t moved after Incannex advised it is in a position to conduct its offering of American Depositary Receipts (ADIs) in January 2022.

    The date finally arrives after a lengthy and intense period taken to address concerns the US Securities and Exchange Commission raised alongside other regulatory headwinds. Incannex’s listed ADSs will trade under the ticker symbol “IXHL”, on the Nasdaq.

    CEO and managing director of Incannex Healthcare, Joel Latham, said it was a “momentous year for Incannex” in 2021 with six research and development programs that “continue to progress rapidly”.

    The company also noted dosing of participants in its phase 2, proof-of-concept clinical trial for IHL-42X is complete.

    The trial is investigating novel cannabinoid combination product, IHL-42X, for the treatment of obstructive sleep apnoea (OSA).

    All participants in the phase 2 trial have now completed the treatment periods. Data is in the hands of Novotech, a contract research organisation. Delivery of the final clinical study report is anticipated in Q1 2022.

    Emyria Ltd (ASX: EMD)

    Emyria was another outperformer in 2021 with shares soaring almost 330% from a base of 9 cents. Shares traded as high as 49.5 cents at one point before finishing the year at 38.5 cents apiece.

    Looking at the chart across the year, shares in the cannabis company were trading flat until they popped in late November.

    Investors piled into the company after it announced a strategic investment at that time. The investment was a vote of confidence for the company seeing as it was made by one of Australia’s largest private investment groups, Tattarang.

    Tattarang is the brainchild of Australian billionaire and recent renewables energy juggernaut Andrew ‘Twiggy’ Forrest AO, chairman and founder of Fortescue Metals Group Limited (ASX: FMG).

    Tattarang invested $5 million via a share placement at a price of 25 cents apiece, giving the investment firm a 7.3% stake in Emyria.

    Funds raised will be put towards its synthetic cannabinoid programs with the Therapeutic Goods Administration (TGA) and the US Food and Drug Administration (FDA).

    The company will also expand its novel MDMA-analogue treatment alongside the University of Western Australia.

    The post These were the best-performing ASX cannabis shares in 2021 appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of August 16th 2021

    More reading

    The author has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3qXjtUp

  • These were the 5 best performing ASX uranium shares of 2021

    A miner stands in front oh an excavator at a mine site

    Last year was an exciting time for those invested in ASX uranium shares. Many sat back to watch the price of uranium surge higher, boosting the share prices of many companies involved in the commodity.

    One of the major catalysts for uranium prices in 2021 was the Sprott Physical Uranium Trust. It snapped up bulk amounts of the energy commodity in the second half of the year, tightening supply on the spot market.

    Here are the ASX stocks that gained the most as uranium rallied in 2021.

    5 top ASX uranium shares of 2021

    A quick note before we start: This list only contains companies with market capitalisations of more than $50 million and share prices of more than 5 cents.

    Alligator Energy Ltd (ASX: AGE) – gained 427%

    The Alligator Energy share price took out the top spot on this list, growing from 1.1 cents to 5.5 cents over the 12 months ended 31 December 2021.

    The company has uranium projects in South Australia and the Northern Territory.

    A-Cap Energy Ltd (ASX: ACB) – up 383%

    A-Cap Energy came in as the second best performing ASX uranium share of 2021.

    The company operates the Letlhakane Uranium Project in Botswana. It also has business in nickel-cobalt mining.

    Its shares ended 2020 trading at 3 cents apiece before gaining 383% to end 2021 valued at 14.5 cents.

    Anson Resources Ltd (ASX: ASN) – up 366%

    The Anson Resources share price surged 366% over the course of 2021. It climbed from just 2.9 cents to 13.5 cents.

    The company is focused on producing resources for the global energy shift. It holds a lithium resource in the United States, a nickel, copper, and platinum group elements project in Western Australia, and the Yellow Cat Vanadium-Uranium project.

    Yellow Cat is located in Utah and is currently in its exploration phase.

    Core Lithium Ltd (ASX: CXO) – gained 321%

    2021 was a great year for the Core Lithium share price. It gained 321% to land as the fourth best performing ASX uranium share.

    After finishing 2020 trading at 14 cents, Core Lithium’s stock was swapping hands for 59 cents come the final close of 2021.

    As the name suggests, Core is a lithium exploration company. However, it owns a uranium tenement in the Northern Territory and the Fitton Uranium Project in South Australia.

    Paladin Energy Ltd (ASX: PDN) – up 266%

    Finally, coming in as the fifth best performing ASX uranium share of 2021 is Paladin Energy.

    The company’s stock grew from 24 cents to 88 cents over the course of last year.

    Paladin Energy is a uranium producer and explorer with operations in Australia and Africa.

    The post These were the 5 best performing ASX uranium shares of 2021 appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of August 16th 2021

    More reading

    Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3G2YzK3

  • Who owns AGL (ASX:AGL) shares and does it really matter?

    close up of man's eye looking through magnifying glass representing asx 200 share price on watch

    The AGL Energy Limited (ASX: AGL) share price is on the rebound following the broader market sell-off witnessed yesterday.

    Currently, the company’s shares are up 1.46% to $6.26, which is around half of the 3.29% loss sustained on Thursday.

    The company has been a hot topic with investors over recent months following its plans to simplify its business model. While the Australian energy giant is making strides, you may be wondering who owns AGL shares, and does it matter?

    A deeper diver into AGL ownership

    The sheer number of shareholders distributed across AGL’s registry totals 148,145 investors as of its most recent annual report.

    Almost 60% of AGL’s shareholders are retail investors who own approximately 391 million AGL shares. This means that the wider public has some power to influence key decisions on matters such as executive bonuses.

    However, as the size of the company’s holdings grows, fewer shareholders control a sizeable equity. In fact, the top 25 shareholders collectively hold less than half of the company’s register.

    It’s no secret that institutions along with hedge funds often invest in well-established companies. As such, institutions make up around 40% of AGL’s entire shareholdings or 263 million shares.

    Next up, private companies acquire just 0.4% of AGL with less than 2.7 million AGL shares held.

    And lastly, individual insiders comprising of directors and the management team who have a stake of 0.1% in AGL. This is roughly 946,000 shares, representing the smallest portion, but not uncommon in medium to large-cap companies.

    That being said, the biggest shareholder in AGL is State Street Global Advisors, Inc., with an ownership of about 8.1%. Taking up the second and third spot is Franklin Resources, and The Vanguard Group, each holding a 4.7% interest in AGL.

    Understanding ownership can certainly add value, particularly if the company is backed by a sound institution. Furthermore, by keepinging an eye out for insider transactions, you can gain a better insight into what to expect. Often when a board or senior leadership member buy or sell the company’s shares, it provides an invaluable signal of whether the share is trading at a bargain or is valued expensively.

    About the AGL share price

    Over the past 12 months, the AGL share price has continued to plummet in value, losing almost 50% for investors. The company’s shares reached an all-time low of $5.10 in November before bargain hunters swooped in.

    Based on valuation grounds, AGL presides a market capitalisation of approximately $4.12 billion, with approximately 658.38 million shares outstanding.

    The post Who owns AGL (ASX:AGL) shares and does it really matter? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in AGL right now?

    Before you consider AGL, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and AGL wasn’t one of them.

    The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of August 16th 2021

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3F7hqlQ

  • Why is the Ramsay (ASX:RHC) share price so volatile today?

    A male Avita Medical doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused

    The Ramsay Health Care Limited (ASX: RHC) share price has pulled back from its intraday highs in afternoon trade.

    At the time of writing, the private hospital operator’s shares are up 0.5% to $68.00.

    This compares to a 2% gain for the Ramsay share price in earlier trade.

    What did Ramsay announce?

    This afternoon Ramsay released an update in relation to the impact that COVID-19 restrictions are having on its operations.

    It notes that the NSW Ministry of Health will introduce restrictions on non-urgent overnight Category 2 and Category 3 elective surgeries at all private hospitals in the state effective 10 January.

    Category 2 admission relates to a condition which is not likely to deteriorate quickly or become an emergency within 90 days. Whereas a Category 3 admission is unlikely to deteriorate quickly and has little potential to become an emergency within 365 days.

    In addition to this, Ramsay highlights that similar changes were made by the Victorian Department of Health and Human Services (DHHS) to surgical restrictions on 6 January. Elective surgery is now restricted to urgent elective surgery procedures.

    Further, neither the DHHS nor the NSW Ministry of Health have provided a date for when these restrictions will end and Ramsay will be able to return to business as usual.

    What will the impact be?

    Ramsay has warned that these and previous surgical restrictions will have a material impact on its earnings in FY 2022. For example, it notes that in the first quarter, COVID related disruptions and costs impacted its Australian earnings by $55 million.

    And while January is the seasonally quietest month of the year in the Australian business, it remains unclear when the current wave of Omicron cases will subside and Ramsay will be able to operate as normal again. This could see the restrictions creep into busier months.

    The post Why is the Ramsay (ASX:RHC) share price so volatile today? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Ramsay right now?

    Before you consider Ramsay, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Ramsay wasn’t one of them.

    The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of August 16th 2021

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3f1O8dT

  • Here are the 3 most heavily traded ASX 200 shares on Friday

    busy trader on the phone in front of board depicting asx share price risers and fallers

    In what would probably be some relief for ASX investors today, the S&P/ASX 200 Index (ASX: XJO) is enjoying something of a rebound after yesterday’s brutal selloff. At the time of writing, the ASX 200 is up a healthy 1.42% at 7,463 points.

    But let’s dive a little deeper and take a look at the ASX shares coming out on top of the market’s share volume charts, according to investing.com.

    3 most traded ASX 200 shares by volume this Friday

    Sydney Airport (ASX: SYD)

    Sydney Airport is first up this Friday. This ASX 200 infrastructure share has watched 8.63 million of its shares take flight around the ASX today. This appears to be a dead rubber. There’s not much in the way of news or announcements out from this company today. And what’s more, the Sydney Airport share price hasn’t done anything of too much note. It’s presently up 0.17% at $8.70 a share. Perhaps investors are furiously trading their shares before Sydney Airport gets delisted from the ASX when its takeover deal is completed.

    South32 Ltd (ASX: S32)

    ASX 200 diversified miner South32 is next up this Friday. At the time of writing, a hefty 10.6 million South32 shares have swapped hands so far. There’s no major news or announcements out of this ASX 200 share today. So we can probably put this volume down to the notable share price fall this resources share has suffered through this Friday. As it stands presently, South32 is down a nasty 1.5% at $3.91 a share. This is probably the cause of the elevated trading volume.

    Pilbara Minerals Ltd (ASX: PLS)

    No stranger to this list, Pilbara Minerals is our final ASX 200 share up today. This lithium producer has had a sizeable 11.54 million shares change owners thus far. Again, there are no major developments out of the company today, so it seems this volume is the result of another large share price move. But in happier news, Pilbara is currently up a robust 2.2% at $3.48 a share. This is the likely smoking gun for the high volumes of Pilbara shares we see being traded today.

    The post Here are the 3 most heavily traded ASX 200 shares on Friday appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of August 16th 2021

    More reading

    Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3zxx6Of

  • What might rising US Treasury yields mean for ASX tech shares?

    Stack of coins rising

    ASX tech shares have pared gains earned throughout 2021 after collectively trending down this past month. Whereas the benchmark S&P/ASX 200 Index (ASX: XJO) has climbed 3% in the past month, the S&P/ASX All Technology index (XTX) is down 4% after sliding another 6% this last week.

    As it stands, a number of macro-economic ‘crosscurrents’ appear to be impacting the share prices of the ASX tech basket in 2022.

    Most notably is the US Federal Reserve’s recent language shift on inflation and its intention to potentially hike rates “at a faster pace than participants had earlier anticipated” from 2022.

    The Fed aims to control inflation and rates via its actions in the US Treasury bond market. It targets the yield (or rate) on various US Treasury debt instruments because these play a pivotal role in asset valuations – stocks in particular – plus aggregate supply and demand.

    In turn, the Fed’s interventions are felt as an impulse throughout the economy. The net result aims to contain inflation and interest rates within certain bands, although this has ramifications for the stock market.

    In fact, any movement at all from the US Fed and the US bond markets are huge inflectors for global share markets, the ASX included.

    The term ‘hawkish’ is now being thrown around investor circles to describe the Fed’s current position on rates, meaning it favours a higher interest rate environment moving forward. This contrasts to previous language from the Fed which suggested rate hikes were a thing of the distant future.

    Now, as a result, global fixed income and share markets are talking, and there’s plenty of chatter around what this all means for high-beta tech stocks on the ASX. Let’s take a look.

    Why are US Treasury yields so important?

    Bonds and notes are a type of debt between an investor and a borrower. For their risk in lending their hard earned capital, bond investors receive interest payments over the tenor and then get their principal back in full when the debt matures.

    Seeing as the US Government is considered as investment grade and highly, highly unlikely to default on its debt at any stage, US Treasury bonds are considered extremely safe assets. In fact, the yield on the US 10-year note or 30-year bond is often dubbed the “risk-free rate” due to this point.

    As such, the yield, or interest rate on US Treasury bonds (and notes) – particularly the 10-year US Treasury note – are considered quintessential numbers in finance.

    Why is this so? Well firstly, central banks use variables like interest rates and Treasury yields to contain or boost the level of GDP, mortgage lending, credit creation and real inflation.

    With inflation soaring in the US, the Fed has little choice but to dial up interest rates in order to wind down surging prices in the real economy. That’s how it goes.

    Back in early 2021, Fed chair Jerome Powell said the Fed was agnostic to hiking interest rates and/or yields until 2023 or 2024 at least, even with pressures from surging inflation.

    Powell used the term “transitionary” to describe the high inflation back then, deeming prices were coming off a low base from 2020 when global economies were in limbo.

    However, amid global supply chain disruptions and manufacturing bottlenecks bought on by the pandemic, inflation statistics were well above targets last year. Inflation data in the US in Q4 2021 alone was 6% year on year for example, its highest in decades.

    The US Fed doesn’t have a button to precisely target inflation figures in the economy. And whilst US Treasury yields don’t impact inflation directly, both measures do have a direct relationship with the Federal Funds Rate (FFR).

    The FFR is akin to the cash rate in Australia and is the interest rate depository institutions charge each other for overnight loans of funds.

    As such the Fed uses the FFR to target changes in short-term interest rates on consumer loans and credit. It will also use it to impact the US treasury yield curve. In turn, these moves create an impulse that either boosts or compresses inflation.

    In Australia, the RBA uses the same approach to influence the level of inflation. In both the US and Australia, the aim is to maintain inflation between 2% to 3% on an annual basis.

    How can US Treasury yields impact ASX tech shares?

    The other and most relevant reason to us why US Treasury yields are so essential boils down to the financial mathematics in how assets are valued.

    According to the CFA Institute, analysts mostly quote the US 10-year yield to value securities using a discounted cash flow valuation (DCF).

    They estimate what a share is worth today using a DCF with either predicted cash flows (either through dividends or company earnings) or earnings multiples, and the US 10-year yield in the equation.

    Hence any shift in the yield curve or yield levels on US Treasuries has a direct impact on valuations for asset classes likes shares.

    These valuations are essential figures that investors draw upon in their own investment reasoning, in addition to performing their own calculations.

    As Warren Buffet says, value is what it’s worth, price is what you pay – so investors seek to understand where a stock is trading relative to its intrinsic value.

    Growth shares by definition are often trading at a substantial premium to their intrinsic value, meaning they are trading at lofty valuations that are sensitive to rates changes.

    The market recognises this and, without factoring absolute numbers in, automatically begins to price in the valuation effect of a shift in yields to growth and tech stocks. This is how shifting US Treasury yields can impact ASX tech shares.

    What might rising US Treasury yields mean for ASX tech shares?

    It is well acknowledged that a hike in nominal interest rates is an essential move to cool off hot-running inflation and house prices bought on by the pandemic.

    However, this creates a problem for ASX tech shares, particularly highly-priced, unprofitable names that are trading at a premium.

    Turning back to our talk on asset valuations, there is an inverse relationship between rates and valuation. A rising rate/yield on the 10-year US Treasury note would compress stock valuations for instance, whereas lower yields are a valuation driver.

    If the Fed does hike rates in order to ring-fence inflation, this will be a net-negative for high-growth tech stocks across the board because the impact is disproportionate to tech companies in general.

    These valuations in turn have a considerable impact on how the market prices a company’s share price, and how investors seek investment opportunities, as mentioned earlier.

    This helps explain why the broad ASX tech indices are down following the Fed’s most recent meeting and the release of its minutes this week, according to analysis from Bloomberg Intelligence.

    Foolish takeaway

    Global share markets have been buoyed from a period of record low interest rates and ample liquidity for the past 10 years after the global financial crisis.

    As such, high-growth tech stocks have flourished during that time, as investors have adopted a risk-on appetite. According to the Nasdaq, investors preferred to have a premium this past decade for a chance at higher gains into the future.

    Fast forward to 2022 and the outlook is far less visible. The US Fed has over $8 trillion in debt on the balance sheet and has ‘printed’ more money in the last 2 years than in the last 50 years combined.

    In Australia, many commercial banks are expecting interest rate hikes to occur in 2023, ahead of the Reserve Bank’s estimates which sit further out. Several have already made hikes to their fixed mortgage rates in 2021, in an attempt to drive interest to floating rate products and to cover costs.

    The pressure is on for a shifting rates regime over the coming years. As such, rising yields on US Treasuries hurts the valuations on ASX tech shares and can ultimately present as a downside risk.

    In consequence, rising US Treasury yields are deemed to be a net-negative for Australian technology shares.

    The post What might rising US Treasury yields mean for ASX tech shares? appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of August 16th 2021

    More reading

    The author has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3n6b2oV

  • Why is the ANZ (ASX:ANZ) share price having such a fab Friday?

    A giant inflatable pig hot air balloon soars high in the sky.

    The Australia and New Zealand Banking Group Ltd (ASX: ANZ) share price is among a raft of financial shares climbing today amid interest rate speculation out of the United States.

    Shares in the banking giant are swapping hands at $28.41 in afternoon trade, up 2.64% on yesterday’s close.

    Joining the ANZ bank in finishing the week on a high is the S&P/ASX 200 Financials Index (ASX: XFJ), up 2.1% at the time of writing.

    Commonwealth Bank of Australia (ASX: CBA) shares are currently trading 2.65% higher while National Australia Bank Ltd. (ASX: NAB) shares are climbing 1.48%. Meanwhile, the Westpac Banking Corp (ASX: WBC) shares are up 1.58%

    The US-based big banks followed a similar trend overnight, with New York Stock Exchange shares in Bank of America Corp up 2.01%, Wells Fargo & Co climbing 2.56% and Citigroup rising 3.28%.

    Let’s take a closer look at what may be impacting investor sentiment today.

    Are interest rates on the rise soon?

    The ANZ Bank has not released any news to the market today. However, interest rate speculation from the United States could be playing into the share price rise.

    According to news reports, the US Federal Reserve is considering fast-tracking interest rate rises this year to March.

    The Wall Street Journal reported rates could be lifted “sooner or at a faster pace than participants had earlier anticipated”. In fact, the publication reported the Fed could raise its rates up to three times this year.

    Global central banks including the Reserve Bank of Australia (RBA) are known to take their lead from the US Federal Reserve. As my Foolish colleague Bernd noted this morning, investors have been keeping a close watch on the Fed for this reason.

    Any movement from the RBA leads to the banks lifting their interest rates too. Interest rate hikes help banks improve their profit margins on loans.

    In December, the RBA kept interest rates constant at 0.1% but removed the note that it would keep them at this level until 2024.

    ANZ share price recap

    The ANZ share price has soared more than 20% in the last 12 months, outperforming the benchmark S&P/ASX 200 Index (ASX: XJO) by about 9 percentage points.

    In the past week, ANZ shares have gained 2%, while they are up 5% in the past month.

    The bank commands a market capitalisation of more than 80 billion based on the current share price.

    The post Why is the ANZ (ASX:ANZ) share price having such a fab Friday? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in ANZ Bank right now?

    Before you consider ANZ Bank, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and ANZ Bank wasn’t one of them.

    The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of August 16th 2021

    More reading

    The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3HLcB3d

  • Is it a buy in 2022? Top brokers focus in on the Woodside (ASX:WPL) share price

    Group of thoughtful business people with eyeglasses reading documents in the office.

    The Woodside Petroleum Limited (ASX: WPL) share price is edging higher in afternoon trade and is now 2.48% in the green at $22.76.

    It’s been a difficult period for the hydrocarbons giant these past 12 months, with shares down almost 7%. A series of updates and controversies saw prices trade as high as $27.40 and as low as $19.20 in that time, whereas shares have been trading sideways since December.

    With the landscape for hydrocarbons players shifting substantially over the coming decade, the horizon for Woodside investors is set to be a colourful one. So, is it a buy in 2022? Here’s what the experts think.

    Is Woodside a buy in 2022?

    The team at Morgans has Woodside as a buy and value the company at $29.95 per share in a recent update.

    Morgans likes Woodside on a number of layers, including its forecasted dividend of $1.21 cents per share in FY22 and $1.06 cents/share in FY23.

    The firm is also constructive on Woodside’s petroleum asset merger with BHP Group Ltd (ASX: BHP). It reckons the company “has benefited from being in the right place, at the right time”, especially as the pair already has existing relationships.

    In the opine of Morgans, Woodside is “clearly getting the better of the deal”, especially as BHP is willing to accept a discount for the deal.

    The deal is “transformative” according to the broker, and will position Woodside “into being a top 10 global E&P with +2 billion barrels of 2P reserves”.

    Back in November, Morgan Stanley was pleasantly surprised at the company’s Scarborough project’s return prospects.

    In making a final investment decision on the project last year, the company estimates an internal rate of return (IRR) of 13.5% and sees a lower breakeven at $5.8/mmbtu.

    Morgan Stanley says the upgrade is likely due to “capex carry from Global Infrastructure Partners should Woodside deliver the downstream for $5.6 billion”.

    Jarden and Credit Suisse are also bullish on Woodside and value the company at $27.80 and $28.32 per share respectively.

    From a list of analysts provided by Bloomberg Intelligence, 73% have Woodside as a buy right now, whereas the remainder have it as a hold or sell.

    Woodside share price summary

    The Woodside share price has started 2022 well and is more than 3% in the green to start the year. Over the past month, it has also climbed more than 5% amid price strengths in the oil markets from December.

    Brent is now up more than 47% for the past 12 months and has climbed over 9% in the last month of trading, although this rate of change has yet to be reflected in Woodside’s shares.

    On the longer-term time frames, the Woodside share price has lagged the S&P/ASX 200 Index (ASX: XJO).

    The post Is it a buy in 2022? Top brokers focus in on the Woodside (ASX:WPL) share price appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Woodside Petroleum right now?

    Before you consider Woodside Petroleum, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Woodside Petroleum wasn’t one of them.

    The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of August 16th 2021

    More reading

    The author has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3eW7aCk

  • Why Afterpay, BrainChip, Medibank, and WiseTech shares are racing higher

    share price rise

    The S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a positive note. In afternoon trade, the benchmark index has rebounded from yesterday’s selloff and is up a sizeable 1.3% to 7,452.5 points.

    Four ASX shares that are climbing more than most today are listed below. Here’s why they are racing higher:

    Afterpay Ltd (ASX: APT)

    The Afterpay share price is up 4% to $74.66. Investors have been buying this buy now pay later provider’s shares after the Block share price recovered slightly on Thursday night. This meant that the takeover proposal that shareholders have approved is now valued at ~$75.66 per share at current exchange rates.

    Brainchip Holdings Ltd (ASX: BRN)

    The Brainchip share price has jumped 11% to 98.5 cents. Investors have been buying this artificial intelligence technology company’s shares this week amid reports that Mercedes has included the Brainchip Akida chip in its Vision EQXX electric concept car. The chip is reportedly being used to power its “Hey Mercedes” smart assistant feature. Though, it is worth noting that this is a concept car and not indicative of future use in other cars.

    Medibank Private Ltd (ASX: MPL)

    The Medibank share price is up 6% to a 52-week high of $3.62. This is despite there being no news out of the private health insurer today. However, investors are becoming increasingly positive on the company due to favourable policyholder growth trends and strong margins.

    WiseTech Global Ltd (ASX: WTC)

    The WiseTech share price is up 3.5% to $55.89. Investors have been buying the logistics solutions company and other tech shares today following a selloff on Thursday. So much so, the S&P ASX All Technology index is up 1.1% in afternoon trade. The WiseTech share price is still down 5% this week despite today’s recovery.

    The post Why Afterpay, BrainChip, Medibank, and WiseTech shares are racing higher appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of August 16th 2021

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Afterpay Limited and WiseTech Global. The Motley Fool Australia owns and has recommended Afterpay Limited and WiseTech Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3zMp2cF